184 related articles for article (PubMed ID: 891391)
1. [Isolated or combined drug therapy of hyperuricemia?].
Mertz DP
Dtsch Med Wochenschr; 1977 Jul; 102(30):1096-7. PubMed ID: 891391
[No Abstract] [Full Text] [Related]
2. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
3. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
Matzkies F
Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
[No Abstract] [Full Text] [Related]
5. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
Matzkies F
Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of hyperuricemia].
Gröbner W
Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
[No Abstract] [Full Text] [Related]
7. [Chronic gout. Case report of a severe course of disease].
Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
[No Abstract] [Full Text] [Related]
8. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
Mertz DP
Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
[No Abstract] [Full Text] [Related]
9. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
Matzkies F; Berg G
Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Hanvivadhanakul P; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerance of long-term uricosuric treatment].
Berg H
Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
[TBL] [Abstract][Full Text] [Related]
13. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Mertz DP
Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
[No Abstract] [Full Text] [Related]
14. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL
Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859
[TBL] [Abstract][Full Text] [Related]
15. [Uricosuric agent].
Ohno I
Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
[TBL] [Abstract][Full Text] [Related]
16. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
Mangini RJ
Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
[No Abstract] [Full Text] [Related]
17. Drugs in the treatment of hyperuricemia.
Elion GB
Adv Nephrol Necker Hosp; 1974; 3():51-7. PubMed ID: 4219708
[No Abstract] [Full Text] [Related]
18. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
Wong ML
N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
[No Abstract] [Full Text] [Related]
19. The treatment of hyperuricemia in gout.
Rastegar A; Thier SO
Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829
[No Abstract] [Full Text] [Related]
20. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
